ArticleScientific reports2025
Effect of inoculation dose on infection kinetics and immune responses to Giardia.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Giardia duodenalis is a globally prevalent enteric parasite capable of establishing both acute and chronic infections. While infection dose is known to influence early infection dynamics, its effect on immune activation and chronicity remains poorly defined. In this study, we investigated how varying inoculum sizes affect infection kinetics and immune development in both immunocompetent (C57BL/6J) and T cell-deficient (TKO) mice. High infection doses induced earlier cyst shedding and accelerated interleukin-17A (IL-17A) responses, while lower infection doses resulted in delayed immune activation. Despite these early differences, cumulative cyst excretion and clearance kinetics eventually converged across dose groups. In TKO mice, infection was not controlled regardless of dose, yet parasite loads plateaued, suggesting host-intrinsic limits to expansion. Longitudinal follow-up in C57BL/6J mice revealed persistent low-level infection and sustained upregulation of IL-17A, mannose-binding lectin 2 (Mbl-2) and inducible nitric oxide synthase (NOS2) up to six months post-infection, despite low trophozoite counts. These findings confirm a central role for IL-17A in anti-giardial immunity and suggest that infection dose modulates the timing but not the outcome of immune control. Persistent IL-17A signaling during chronic infection may contribute to long-term host-pathogen interactions, with potential implications for intestinal health and secondary pathogen resistance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.